UniSa - IRIS Institutional Research Information System

TRIGGIANI, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 10.200
NA - Nord America 9.215
EU - Europa 2.316
SA - Sud America 876
AF - Africa 57
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 5
Totale 22.685
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.119
HK - Hong Kong 6.773
SG - Singapore 1.443
CN - Cina 813
BR - Brasile 722
VN - Vietnam 534
UA - Ucraina 501
IT - Italia 497
RU - Federazione Russa 344
DE - Germania 306
TR - Turchia 241
IE - Irlanda 210
KR - Corea 187
FI - Finlandia 122
SE - Svezia 83
AR - Argentina 81
GB - Regno Unito 79
CA - Canada 47
IN - India 46
AT - Austria 34
ES - Italia 28
EC - Ecuador 27
MX - Messico 27
ID - Indonesia 26
BD - Bangladesh 22
PL - Polonia 22
IQ - Iraq 18
JP - Giappone 18
ZA - Sudafrica 16
NL - Olanda 15
FR - Francia 13
CO - Colombia 12
AE - Emirati Arabi Uniti 11
CZ - Repubblica Ceca 10
NZ - Nuova Zelanda 10
PK - Pakistan 10
PY - Paraguay 9
LT - Lituania 8
PE - Perù 8
CH - Svizzera 7
UZ - Uzbekistan 7
VE - Venezuela 7
AU - Australia 6
JO - Giordania 6
MA - Marocco 6
CL - Cile 5
EG - Egitto 5
IL - Israele 5
KE - Kenya 5
AM - Armenia 4
CR - Costa Rica 4
EU - Europa 4
GR - Grecia 4
MD - Moldavia 4
MY - Malesia 4
PA - Panama 4
PT - Portogallo 4
BE - Belgio 3
GN - Guinea 3
HU - Ungheria 3
KZ - Kazakistan 3
MK - Macedonia 3
NI - Nicaragua 3
PS - Palestinian Territory 3
SA - Arabia Saudita 3
UY - Uruguay 3
AL - Albania 2
AZ - Azerbaigian 2
BF - Burkina Faso 2
BN - Brunei Darussalam 2
BZ - Belize 2
CI - Costa d'Avorio 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GP - Guadalupe 2
JM - Giamaica 2
KG - Kirghizistan 2
NG - Nigeria 2
OM - Oman 2
RS - Serbia 2
SI - Slovenia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
ZM - Zambia 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BJ - Benin 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
Totale 22.663
Salva come PNG Salva come JPEG
Città #
Hong Kong 6.773
Ann Arbor 2.093
Woodbridge 1.132
Chandler 699
Jacksonville 662
Princeton 627
Singapore 590
Houston 541
Dallas 524
Ashburn 392
Wilmington 392
Dong Ket 326
Izmir 223
Dublin 207
Beijing 148
Andover 147
Nanjing 133
Boardman 113
Moscow 104
Pellezzano 103
Ho Chi Minh City 81
Munich 79
Los Angeles 78
New York 63
Naples 61
Nuremberg 56
Salerno 55
Washington 55
São Paulo 54
The Dalles 53
Düsseldorf 50
Shenyang 49
Changsha 45
Fairfield 45
Hebei 42
Columbus 41
Norwalk 39
Jiaxing 38
Nanchang 37
Redwood City 37
Buenos Aires 34
Hanoi 30
Council Bluffs 27
Dearborn 27
Rio de Janeiro 26
Santa Clara 25
Tianjin 25
Lappeenranta 22
Turku 22
Montreal 21
Brooklyn 20
Rome 20
Chicago 19
Seattle 19
Warsaw 19
Boston 18
Mestre 18
Poplar 18
London 17
Milan 16
Tokyo 16
Belo Horizonte 15
Pune 15
Vienna 15
Denver 14
Phoenix 14
Seoul 14
Quito 13
Cambridge 11
Chennai 11
Curitiba 11
Haiphong 11
Atlanta 10
Brasília 10
Charlotte 10
Latina 10
Raleigh 10
Stockholm 10
Amsterdam 9
Falls Church 9
Jinan 9
Mexico City 9
Biên Hòa 8
Brno 8
Guangzhou 8
Johannesburg 8
Orem 8
San Diego 8
San Francisco 8
San Jose 8
Shanghai 8
Volta Redonda 8
Asunción 7
Baghdad 7
Da Nang 7
Guayaquil 7
Istanbul 7
Jakarta 7
New Delhi 7
Salvador 7
Totale 17.822
Salva come PNG Salva come JPEG
Nome #
Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project) 938
La triptasi sierica nella diagnosi di mastocitosi sistemica in pazienti adulti senza lesioni cutanee 629
Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control 543
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study 526
Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User's Guide for Daily Clinical Practice 505
Fragments of truth: T-cell targets of polyclonal immunoglobulins in autoimmune diseases 470
Triggers and prodromal symptoms of angioedema attacks in patients with hereditary angioedema 372
Control of arachidonate levels within inflammatory cells. 360
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: Data from the Campania Rare Disease Registry 333
A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy 330
Anaphylaxis and cardiovascular diseases 306
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma 287
The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT 263
KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis 256
Integrated care pathways for airway diseases (AIRWAYS-ICPs) 249
Multidisciplinary challenges inmastocytosis and how to address with personalizedmedicine approaches 214
Immunoglobulin G (IgG) anticardiolipin antibodies and recurrent cardiovascular events. A systematic review and Bayesian meta-regression analysis 213
Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: A Work Group Report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & Immunology 200
Characterization of platelet-activating factor synthesized by normal and granulocyte-macrophage colony-stimulating factor-primed human eosinophils. 193
A review of hereditary angioedema and recombinant human C1-inhibitor treatment 190
Diagnostic and therapeutic management of hereditary angioedema due to C1-inhibitor deficiency: The Italian experience 186
Heterogeneity of human Fc epsilon RI-bearing cells. 181
A randomised, placebo-controlled, double blind phase III study of the efficacy and safety of recombinant human C1 inhibitor for the treatment of acute attacks in patients with hereditary angioedema 181
Antigen-induced generation of lyso-phospholipids in human airways. 164
Secretory phospholipases A2 activate selective functions in human eosinophils 161
Stress and Psychological Factors in the Variable Clinical Phenotype of Hereditary Angioedema in Children: A Pilot Study 156
Allergia alimentare e probiotici: nuovi aspetti sulle interazioni tra il sistema immunitario ed i batteri commensali intestinali 152
Arachidonic acid metabolism during antigen and ionophore activation of the mouse bone marrow derived mast cell. 148
Activation of human basophils by staphylococcal protein A. I. The role of cyclic AMP, arachidonic acid metabolites, microtubules and microfilaments. 147
Activation of human inflammatory cells by secreted phospholipases A2 141
Current concepts on diagnosis and treatment of mastocytosis. 137
Molecular and cellular biology of mast cells and basophils. 134
Activation of cytokine production by secreted phospholipase A2 in human lung macrophages expressing the M-type receptor 134
Antileucotrieni nell'asma bronchiale: bilancio e prospettive 132
Advances in the classification and treatment of mastocytosis: Current status and outlook toward the future 130
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 124
Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases 124
A unique case of angioedema with anti-C1 inhibitor antibodies and normal C1 inhibitor levels 121
Non lymphomatous clonal B-Cell populations in enlarged lymph nodes in acquired immunodeficiency syndrome. 121
Editorial overview: Immunomodulation: Modulation of the immune system: Per aspera ad astra 120
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis 119
Biochemical functions of a pool of arachidonic acid associated with triglycerides in human inflammatory cells. 117
Human Macrophages and Monocytes Express Functional Na+/Ca2+ Exchangers 1 and 3Sodium Calcium Exchange: A Growing Spectrum of Pathophysiological Implications 117
Assay of antibody to group A streptococcal carbohydrate by enzyme-linked immunosorbent assay. 114
L'acido ialuronico nella regolazione delle risposte infiammatorie ed immunologiche 114
Pharmacological modulation of human mast cells and basophils 114
Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group 113
Enhanced Expression of CD47 Is Associated With Off-Target Resistance to Tyrosine Kinase Inhibitor Gefitinib in NSCLC 112
Home Therapy with Plasma-Derived C1 Inhibitor: A Strategy to Improve Clinical Outcomes and Costs in Hereditary Angioedema 110
Benzene metabolites inhibit the release of proinflammatory mediators and cytokines from human basophils 110
A Survey of Clinical Features of Allergic Rhinitis in Adults 109
Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study 108
AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation 108
Molecular diagnosis and the Italian Board for ISAC. 107
Are mast cells MASTers in HIV-1 infection? 107
Biological effects of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in the human neutrophil. 106
Elevated plasma levels of vascular permeability factors in C1 inhibitor-deficient hereditary angioedema 106
Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions 105
360 degree perspective on allergic rhinitis management in Italy: A survey of GPs, pharmacists and patients 103
Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal 102
What we should learn from the London Olympics 101
Relative amounts of 1-O-alkyl- and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in stimulated endothelial cells. 99
Expression and function of angiopoietins and their tie receptors in human basophils and mast cells 99
Research needs in allergy: an EAACI position paper, in collaboration with EFA 98
Inhibition of IgE-mediated release of histamine and peptide leukotriene from human basophils and mast cells by forskolin. 97
Secretory phospholipases A2 in inflammatory and allergic diseases: not just enzymes. 97
Biomarkers for evaluation of mast cell and basophil activation 97
Sensitization to Common and Uncommon Pets or Other Furry Animals: Which May Be Common Mechanisms? 96
Arachidonic acid remodeling in human inflammatory cells migrating to the lung in vivo. 96
Role of human FcεRI+ cells in HIV-1 infection 95
Evaluation of vaccination safety in children with mastocytosis 95
Mast cells as effector cells of innate immunity and regulators of adaptive immunity 94
HIV-1 envelope gp41 peptides promote migration of human FcεRI+ cells and inhibit IL-13 synthesis through interaction with formyl peptide receptors 93
Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor. 92
Factors that influence the proportions of platelet-activating factor and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine synthesized by the mast cell. 92
Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation. 92
Component resolved diagnosis (CRD): how much is it presently used by Italian allergists? 92
Perioperative anaphylactic risk score for risk-oriented premedication. 92
Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis 91
Migration of human inflammatory cells into the lung results in the remodeling of arachidonic acid into a triglyceride pool. 90
Inhibition of histamine and prostaglandin D2 release from human lung mast cells by ciclosporin A. 90
Role of human mast cells and basophils in bronchial asthma. 90
Management of chronic spontaneous urticaria: practical parameters 90
Metabolism of platelet-activating factor in the guinea-pig heart. 89
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement 89
Mastocytosis presenting as cardiac emergency 89
Oxidative stress markers are increased in patients with mastocytosis 88
Studi tossicologici sugli effetti dell'idrochinone e del benzochinone sui basofili umani 88
Phenotypical and functional heterogeneity of human lung macrophages 88
European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives 88
Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: An expert opinion 88
Hereditary and Acquired Angioedema: Heterogeneity of Pathogenesis and Clinical Phenotypes 88
Simplexide Induces CD1d-Dependent Cytokine and Chemokine Production from Human Monocytes 87
Influence of immunologic activation and cellular fatty acid levels on the catabolism of platelet-activating factor within the murine mast cell (PT-18). 87
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients 87
Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study. 86
Inhibition of IgE-mediated histamine release from human basophils and mast cells by fenoterol. 86
Metabolism of lipid mediators in human basophils and mast cells. 86
Mutational Spectrum of the C1 Inhibitor Gene in a Cohort of Italian Patients with Hereditary Angioedema: Description of Nine Novel Mutations 86
Inhibition of secretory phospholipase A2-induced cytokine production in human lung macrophages by budesonide 86
Totale 16.126
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.995
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.995
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021923 0 0 0 0 151 46 150 22 91 11 99 353
2021/20221.047 9 3 4 18 10 19 9 44 166 139 137 489
2022/20231.740 184 104 59 200 244 388 12 165 260 6 93 25
2023/20241.002 82 110 122 49 97 174 23 44 11 40 47 203
2024/20252.428 79 34 33 96 109 283 353 246 465 199 281 250
2025/20269.593 1.342 3.676 3.071 568 936 0 0 0 0 0 0 0
Totale 22.991